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Abstract: 
Purpose: To develop a multi-criteria optimization framework for image guided 
radiotherapy. 
Methods: An algorithm is proposed for a multi-criteria framework for the purpose of 
patient setup verification decision processes. Optimal patient setup shifts and rotations are 
not always straightforward, particularly for deformable or moving targets of the spine, 
abdomen, thorax, breast, head and neck and limbs. The algorithm relies upon dosimetric 
constraints and objectives to aid in the patient setup such that the patient is setup to 
maximize tumor dose coverage and minimize dose to organs at risk while allowing for 
daily clinical changes. A simple 1D model and a lung lesion are presented.  
Results: The algorithm delivers a multi-criteria optimization framework allowing for 
clinical decisions to accommodate patient target variation make setup decisions less 
straightforward. With dosimetric considerations, optimal patient positions can be derived. 
Conclusions: A multi-criteria framework is demonstrated to aid in the patient setup and 
determine the most appropriate daily position considering dosimetric goals. 
 
1. Introduction 
Image guided radiotherapy can deliver higher levels of confidence in accurate radiation delivery 
to patients. Using 2D (radiographs)1-7 or 3D (e.g. cone beam computed tomography (CBCT))6, 8-17 
imaging at the time of treatment can aid in the accurate positioning of a patient and the 
geometrically confident delivery of radiation dose to the prescribed target. When treating targets 
that move and/or deform in the spine, abdomen, thorax, head and neck, breast and limbs, image 
guidance might not provide simple or straightforward patient shift calculations2, 4, 11, 18-21. 
Additionally, shifts generated from bony anatomy might not directly or accurately reflect the 
daily variation of a soft tissue target not attached to the bony structure11, 18, 19. Finally, it is well 
known that head and neck cancers can change size during the treatment fractionation and result in 
large changes in dosimetry to the target and surrounding organs at risk (OARs)22.  
To develop more accurate image guidance, several procedures have been proposed. Repeat CT 
and CBCT scanning is often utilized to provide a 3D alignment assessment but deformable and 
moving targets can not be easily aligned using static 3D images and rigid alignment techniques8, 
18, 19, 23, 24. Additionally, the alignment is generally performed using surrogates that have variable 
degrees of fidelity for positioning the poorly visualized tumor and surrounding organs at risk 
(typically either bony anatomy or soft tissue or a manual attempt at averaging the two)11, 18-20. 
Some groups have suggested performing daily dose calculations on the daily CT or CBCT for 
more informed dosimetry evaluations23, 24. While this concept has merit, both logistic (calculation 
speed and infrastructure) as well as accuracy (dependence on accurate deformable modeling and 
dose re-calculation/summation) limitations hinder current implementation. 
Multi-criteria approaches allow experts to understand the tradeoffs inherent in their decisions, and 
have demonstrated usefulness in guiding treatment planning optimization25-27.  Currently, no 
study has presented a multi-criteria approach to the address the tradeoffs within image guidance. 
To this end, we propose an algorithm that can interactively aid in the patient setup decision 
making process, utilizing a multi-criteria optimization interface. 
 
2. Methods 
2.1. Image Guidance Workflow 
We propose the following workflow as a foundation for this algorithm:  
 
 
 
 
 
The patient simulation CT0 would be transferred to a shared computer capable of performing a 
deformable registration. The daily CBCTn or CTn would be transferred to the shared computer 
and the CT0 would be deformably registered to the CBCTn or CTn. Dose would be recalculated on 
the deformed CT0 and used in the MCO algorithm. The MCO algorithm produces a 
recommended patient shift that accounts for the dosimetric considerations of the clinical protocol. 
Patient would be shifted and treated or shifted and reimaged for a repeat of the process. 
2.2. MCO for Image Guidance 
Similar to MCO for treatment planning25-27, the dose delivered to the patient is modified on a 
continual variable space to generate a Pareto surface. Instead of altering the fluence or beam 
parameters, the MCO-IG algorithm generates a Pareto from shifts and rotations of the patient. 
Additionally, the MCO-IG algorithm can include beam weights for non-IMRT beams or multiple 
plans in the optimization process. In general, the Pareto surface would be generated from the 
following system of equations: 
Mi (r) = wi, j Dj (r),  s.t.
j=1
n
∑  DGTV ≥ DlimGTV  and DOAR ≤ DlimOAR    (1) 
where Dj(r) is a constraint or objective with weight, wi,j, for a patient shift, r, and the Pareto 
surface defined by all possible values of Mi(r) is a function of the patient shifts and the weights of 
the objectives and constraints summed over all j={1,n} objectives or constraints. 
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2.3. Simple 1D Model 
For a GTV separated from an OAR by distance Δx that can vary with each daily treatment 
fraction, there is a dose curve, D(x), with a 80%-20% penumbra of 2 mm, Figure 1, where the 
ideal (planning) position of the GTV is given such that the GTV receives 99% of the dose. A 
simple version of Eq 1 can be reduced to a two constraint problem, dose to GTV and dose to 
OAR as a function of r = x, the setup position:  
Mi (x) = wi,GTV DGTV (x)+wi,OARDOAR (x)      (2) 
where x can vary to provide a better compromise of constraints and solutions and wi is a variable 
weighting between the dose to the GTV and the dose to the OAR. To simplify the display of the 
solution, we can substitute the weights of the equation by a ratio of the weights: 
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The solutions of Equation 3 can be constrained by the DGTV such that a certain prescription level 
is attained or permitted to float with variable weights depending upon the clinical case.  
For example, assume the GTV and OAR are separated by Δx = 1,2,or 3 mm’s depending upon the 
fraction. A clinical scenario might include a lung tumor that has drifted closer to or farther from 
the liver and diaphragm or a prostate that has drifted closer to or farther from the rectum. From 
Equation 3, optimal setup positions can be determined such that the constraints or objectives are 
met for the given weights.  
 
Figure 1: Dose profile as a function of position, x. The ideal position of the GTV is noted as the 
location where the GTV receives 99% of the dose. 
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Figure 2. A lung lesion with nearby OAR’s of the spinal cord and the esophagus. Simulated 
treatment position variations of +/- 2 mm are demonstrated on the enlarged image. The dose in (a) 
is normalized to the 70% isodose line for a 48 Gy prescription. 
2.4. 2D Lung Case 
For a lung lesion demonstrated in Figure 2, there are two OAR’s in the vicinity of the GTV: the 
esophagus and the spinal cord. Small shifts in the position of the patient, relative to the planned 
dosimetric isocenter can result in large differences in the dose delivered to the OAR’s and GTV 
by pure geometric shifts of the OAR or GTV within the dose cube. 
In the 2D example, equation 3 will change such that x  x,y without consideration of rotations. 
As a first order approximation over small deviations of position of the patient, the dose cube will 
be assumed to remain constant and doses to the OAR’s and GTV will change only as a function 
of the shifts in x,y.  
For the purpose of simulating possible shifts of the GTV from the time of simulation to the 
treatment delivery, two relative shifts of the GTV with respect to the OAR’s are displayed in 
figure 2b, one of -2mm toward the OAR’s and one of +2mm away from the OAR’s. 
In the clinical scenario of the lung lesion, the spinal cord might have a tight dose gradient nearby 
and the physician would prefer less dose to the OAR while compromising the inferior medial 
edge of the GTV. Or, if the distance increased between simulation and the treatment fraction, the 
clinician might prefer to deliver a higher isodose to the PTV. In either case the relative weights 
between the DPTV and the DOAR would reflect the clinical decision at the time of treatment and an 
optimal setup position would be determined. 
For the case displayed in Figure 2, the treatment plan was developed in CMS (Elekta, St Louis, 
MO USA) using 12 conformal beams. The prescription dose was 48 Gy in 4 fractions and was 
prescribed to the 70% isodose line. The high dose region is not centered on the GTV due to the 
proximity of the OAR’s and a clinical decision to pull the high dose region away from the 
OAR’s. The dose distribution of this patient specific example will influence the results of the 
MCO calculations. 
 Figure 3: The optimal shifts for the varying ratio of the weights given in Equation 3. The shift of 
zero corresponds to the GTV receiving 99% of the dose. The asymptotic regions correspond to 
the GTV receiving 100% of the dose (the right side) and the OAR being completely avoided (left 
side).  
 
Figure 4: Dose to the GTV and OAR as a function of the weighting ratio in Equation 3 and 
separation between the GTV and OAR. The 1 mm case is given by the black solid and dotted 
black line for the GTV and OAR, respectively. The range of optimal cases is limited by the small 
separation of the GTV and OAR.  Larger separations provide greater flexibility of optimal setup 
positions and greater choices for the clinician. 
 
3. Results  
The simple 1D model solution of the equation is presented for the 1,2, and 3 mm separations in 
Figures 3 and 4 as a function of the relative offset position compared to a perfect alignment of the 
GTV to the planning position and as a function of the resulting dose to the GTV and OAR’s. A 
negative shift is equal to moving the GTV/OAR to the left in the dose plot of Figure 1 such that 
the doses to the GTV and OAR decrease. The clinician can make a more educated decision 
regarding the optimal setup position of the GTV given this information. 
 
Figure 5. The optimal shift of the patient is displayed versus the respective dose to the OAR for a given 
dose constraint to the GTV. The solution is straightforward in 1 dimension as the algorithm  pushes the 
GTV to the left (negative) until the dose constraint is met. 
In Figure 3, the slope of the line for the 3 mm separation is less than the 1 and 2 mm separation 
cases due to the reduced impact of shifts to Equation 3 because the dose to OAR and thus has less 
impact on the optimization equation. Figure 3 displays the resulting doses to the GTV and OAR 
for the variable weighting ratio and for the three separation scenarios. As can be seen from the 
plot, the smallest separation results in a limited range of weighting factors over which the 
optimization can be performed. When the separation increases to 3 mm, the range of weighting 
values increases, providing greater flexibility in solutions.  
Additionally, Figure 5 presents the optimal shifts for constraints of dose to the GTV such that the 
minimum dose is 99%, 95%, and 90%. As can be seen, in this simple 1D model, the shifts 
determined by the MCO simply force the GTV to the left until the dose limit is achieved. Since 
the ideal position of the GTV is such that it receives 99% of the dose, the D99 points all produce 
a 0 magnitude shift. The other shifts correspond to the distance of the dose limit along of the dose 
curve from the ideal position. For more complicated combinations of translations, rotations and 
dose distributions, the optimal patient shift would not be straightforward. 
For the 2D lung GTV example of Figure 2, the dose is constrained by the OAR’s in the vicinity of 
the GTV. As an example of possible differences between simulation and treatment, two relative 
offsets of the GTV with respect to the OAR’s and patient were included, 2 mm toward the OAR’s 
and 2 mm away from the OAR’s.  
Figure 6 displays the average doses to the OAR’s (DOAR(x,y)) and the minimum dose to the GTV 
(DGTV(x,y)) as functions of various positions of the isocenter. Figure 6a is for the planned relative 
positions of the GTV and OAR’s and (b) and (c) are for the relative shifts of the GTV toward and 
away from the OAR’s, respectively.  
The local maxima of the 2D version of equation 3 are also provided as large “+” symbols on 
figure 6a and it can be seen that equation 3 maximizes on a line along the minimum OAR doses 
and maximal GTV minimum dose. Also, figure 6a displays the global maxima for relative 
weighting factors of 1,1/5 and 1/10 as the large square, circle, and triangle, respectively. The 
shifts suggested by the optimal solutions of equation 3 for the three different weighting ratios are 
displayed in Figure 7 as black dots.  
In the case of the patient specific lung example, the dose distribution is not ideally centered on the 
GTV due to the planning constraints of the OAR’s in the vicinity of the GTV and thus the 
recommended shifts of the patients tend to shift the GTV more into the higher dose region of the 
dose distribution when the dose to the OAR’s are not heavily weighted.  
In the planned isocenter case, figure 6a, it can be seen that the optimal patient position might not 
be the planned isocentric setup. Rather, the dose to the GTV could have been increased by almost 
10 Gy for a modest increase of 0.5 Gy to the OAR’s (Ratio of 1/5 position in figure 7 and large  
a. b. 
c. 
Figure 6. The dosimetric results (DGTV(x,y) and DOAR(x,y)) for the GTV and the OAR’s when 
simulating an ideal reproducible setup (a), an offset of -2 mm from the planned position (b), 
and an offset of +2 mm from the planned position (c). The large X corresponds to planned dose 
distribution with perfect setup. The large + symbols in (a) correspond to the local maxima of 
the equation 3, and the square, circle and triangle correspond to the global maxima of equation 
three for relative weights of 1,1/5, and 1/10, respectively. The prescription dose was 48 Gy at 
the 70% isodose level. 	  
circle on figure 6a) with a small shift of the patient position from the planned position. In other 
words, assuming the patient position on the day of treatment exactly matched the simulation 
position, the dose to the GTV could have been increased nearly 10 Gy with only an extra 0.5 Gy 
to the OAR’s with a small shift in the patient position. Conversely, the prescription isodose could 
have been raised to 85% to achieve the same dosimetric coverage of the GTV and greatly 
reducing the dose to the healthy tissue. 
In the case that the GTV shifts from the planned position relative to the OAR’s (figures 6b and 
6c), it is evident that compromises of planned dose and OAR dose need to be made when the 
relative distance between the GTV and OAR’s decreases. When the distance increases, greater 
dose can be delivered to the GTV and less dose to the OAR’s for a given shift in the patient 
position.  
 
4. Conclusions 
Image guidance in radiotherapy is not a simple process for some patients, particularly when the 
target moves within the patient or the daily patient setup introduces patient deformations. In the 
cases when the optimal patient position is not straightforward, MCO-IG might provide a more 
extensive consideration of the possible solutions that incorporate the dosimetric aims of the 
clinical protocol.  
The simple 1D solution presented in this paper can be easily solved without MCO but it serves to 
demonstrate the scenarios where MCO might aid the determination of the optimal patient position 
for a given treatment fraction. Given a variable of GTV and OAR separation, the model presents 
multiple possible solutions from which the clinician can select the preferred patient shift. 
A 2D example demonstrates that for a patient specific dose distribution, a planned patient 
position might not deliver the ideal dose to the GTV and OAR’s and instead a small shift in the 
patient position from the planned position can increase the dose to the GTV for equivalent OAR 
doses. Additionally, relative shifts in the GTV with respect to the OAR’s can require 
compromises of doses to the GTV and OAR’s if the distance between the high dose regions and 
Figure 7. A display of the effective offsets as determined from the 2D version of equation 3 
for three different relative weighting factors, 1,1/5, and 1/10 of GTV/OAR doses. 	  
the OAR’s decreases. Or, GTV doses can be increased without an increase of dose to OAR’s 
when the distance between the GTV and OAR increases. 
A more complicated case would include more than two dose constraints (i.e. DMAX to the cord, 
gEUD, NTCP) and all six degrees of patient position freedom to form a muli-dimensional Pareto 
surface. Additionally, the MCO algorithm could include beam weights as a variable for simple 
3D conformal fields or multiple plans for intensity modulated deliveries. The ultimate goal is to 
deliver the optimal treatment plan considering daily patient variations given a set of dosimetric 
goals and MCO is a possible solution for achieving this aim. 
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